GGrantIndex
← Leaderboards

Patrizia Farci

Niaid Extramural Activities

$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

By mechanism

Top collaborators

No co-investigators on record.

Most similar at Niaid Extramural Activities

Same institution · by research overlap

Others in their field

Top investigators on “Genes

Research focus

GenesViralCessation Of LifeAcuteMolecularPathogenesisVirusCirrhosisB-LymphocytesPrimary Carcinoma Of The Liver CellsLiverSpecimenInfectionHepaticAntibodiesHepatocarcinogenesisRisk FactorsHepatitis BImmunoglobulin GT-LymphocyteChronic Viral HepatitisHepatitis VirusesAcute Liver FailureHepatitis B Virus

Grant awards (23)

Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$2,141,672
ZIA · FY2025 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$2,252,657
ZIA · FY2024 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$2,109,490
ZIA · FY2023 · AI · contact PI
Generation of Neutralizing Monoclonal Antibodies Against SARS-CoV-2 for Prevention and Therapy in Patients with COVID-19$47,982
ZIA · FY2023 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$1,790,298
ZIA · FY2022 · AI · contact PI
Generation of Neutralizing Monoclonal Antibodies Against SARS-CoV-2 for Prevention and Therapy in Patients with COVID-19$47,717
ZIA · FY2022 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$1,834,212
ZIA · FY2021 · AI · contact PI
Generation of Neutralizing Monoclonal Antibodies Against SARS-CoV-2 for Prevention and Therapy in Patients with COVID-19$47,482
ZIA · FY2021 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$1,859,055
ZIA · FY2020 · AI · contact PI
Generation of Neutralizing Monoclonal Antibodies Against SARS-CoV2 for Immunotherapy of Patients with COVID-19$71,286
ZIA · FY2020 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$1,734,905
ZIA · FY2019 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$1,662,693
ZIA · FY2018 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$2,049,409
ZIA · FY2017 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$1,253,600
ZIA · FY2016 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$1,265,745
ZIA · FY2015 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$1,246,547
ZIA · FY2014 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$1,203,264
ZIA · FY2013 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$872,822
ZIA · FY2012 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$875,428
ZIA · FY2011 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$551,347
ZIA · FY2010 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$637,742
ZIA · FY2009 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases$603,252
Z01 · FY2008 · AI · contact PI
Molecular Mechanisms of Pathogenesis of Chronic Viral Hepatitis$347,763
Z01 · FY2007 · AI · contact PI